Javascript must be enabled to continue!
Vitamin D Levels and Il28B Polymorphisms are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis C
View through CrossRef
Background
Genotype 1 (G1) chronic hepatitis C (CHC) patients achieving a rapid virological response (RVR) on pegylated interferon (PEG-IFN) plus ribavirin have a high chance of sustained virological response (SVR), influenced by IL28B status, viral load, fibrosis and insulin resistance. We assessed whether 25-hydroxyvitamin D (25[OH]D) serum levels are linked to RVR and can be used together with IL28B to construct a pretreatment model to predict RVR.
Methods
A total of 117 consecutive patients with G1 CHC were evaluated by biopsy and anthropometric and metabolic measurements. 25(OH)D serum levels were measured by HPLC. IL28B rs12979860 and rs8099917 polymorphisms were also evaluated. All patients underwent antiviral therapy with PEG-IFN-α2a plus ribavirin. HCV RNA was assessed at baseline, week 4, week 12, at the end of therapy and after 6 months of follow-up.
Results
Mean ±sd 25(OH)D serum levels were 26.3 ±10.6 μg/l (range 8.0–58.0) and 31 (26.5%) patients had the rs12979860 CC polymorphism. RVR was achieved in 35 (29.9%) patients, and 32 (91.4%) of them had an SVR, compared to 26 of 82 (31.7%) without RVR. The rs12979860 CC polymorphism (OR 4.575, 95% CI 1.761, 11.889; P=0.002) and higher 25(OH)D levels (OR 1.055, 95% CI 1.010, 1.101; P=0.01) were independently associated with the achievement of RVR by multivariate analysis. The likelihood of RVR progressively increased from patients in the worst class (vitamin D<26.8 μg/l and TT/TC polymorphism; RVR 14.2%), to those with only one positive predictor (RVR 29.7% and 37.5%), and to those in the best class (vitamin D≥26.8 μg/l and rs12979860 CC polymorphism; RVR 73.3%).
Conclusions
In patients with G1 CHC, 25(OH)D serum levels and IL28B status are independently associated with the likelihood to achieve RVR and SVR. When incorporated into a pretreatment predictive model they can assist in further discriminating patients with a high likelihood of achieving RVR and SVR.
Title: Vitamin D Levels and Il28B Polymorphisms are Related to Rapid Virological Response to Standard of Care in Genotype 1 Chronic Hepatitis C
Description:
Background
Genotype 1 (G1) chronic hepatitis C (CHC) patients achieving a rapid virological response (RVR) on pegylated interferon (PEG-IFN) plus ribavirin have a high chance of sustained virological response (SVR), influenced by IL28B status, viral load, fibrosis and insulin resistance.
We assessed whether 25-hydroxyvitamin D (25[OH]D) serum levels are linked to RVR and can be used together with IL28B to construct a pretreatment model to predict RVR.
Methods
A total of 117 consecutive patients with G1 CHC were evaluated by biopsy and anthropometric and metabolic measurements.
25(OH)D serum levels were measured by HPLC.
IL28B rs12979860 and rs8099917 polymorphisms were also evaluated.
All patients underwent antiviral therapy with PEG-IFN-α2a plus ribavirin.
HCV RNA was assessed at baseline, week 4, week 12, at the end of therapy and after 6 months of follow-up.
Results
Mean ±sd 25(OH)D serum levels were 26.
3 ±10.
6 μg/l (range 8.
0–58.
0) and 31 (26.
5%) patients had the rs12979860 CC polymorphism.
RVR was achieved in 35 (29.
9%) patients, and 32 (91.
4%) of them had an SVR, compared to 26 of 82 (31.
7%) without RVR.
The rs12979860 CC polymorphism (OR 4.
575, 95% CI 1.
761, 11.
889; P=0.
002) and higher 25(OH)D levels (OR 1.
055, 95% CI 1.
010, 1.
101; P=0.
01) were independently associated with the achievement of RVR by multivariate analysis.
The likelihood of RVR progressively increased from patients in the worst class (vitamin D<26.
8 μg/l and TT/TC polymorphism; RVR 14.
2%), to those with only one positive predictor (RVR 29.
7% and 37.
5%), and to those in the best class (vitamin D≥26.
8 μg/l and rs12979860 CC polymorphism; RVR 73.
3%).
Conclusions
In patients with G1 CHC, 25(OH)D serum levels and IL28B status are independently associated with the likelihood to achieve RVR and SVR.
When incorporated into a pretreatment predictive model they can assist in further discriminating patients with a high likelihood of achieving RVR and SVR.
Related Results
The Impact of IL28B Gene Polymorphisms on Drug Responses
The Impact of IL28B Gene Polymorphisms on Drug Responses
To achieve high therapeutic efficacy in the patient, information on pharmacokinetics, pharmacodynamics, and pharmacogenetics is required. With the development of science and techno...
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
VITAMIN D INSUFFICIENCY IN FOUR MAJOR HOSPITALS OF PUNJAB
Objective: To demonstrate vitamin D deficiency in the general population of Punjab
Study Design: Observational, Cross-Sectional
Place and Duration: Multicentre study co...
IL28B Alleles Associated With Poor Hepatitis C Virus (HCV) Clearance Protect Against Inflammation and Fibrosis in Patients Infected With Non-1 HCV Genotypes
IL28B Alleles Associated With Poor Hepatitis C Virus (HCV) Clearance Protect Against Inflammation and Fibrosis in Patients Infected With Non-1 HCV Genotypes
Abstract
Genetic polymorphisms near
IL28...
Study of IL28B gene variation as a predictor of response to directly acting antiviral therapy in hepatic transplantation hepatitis C Egyptian patients
Study of IL28B gene variation as a predictor of response to directly acting antiviral therapy in hepatic transplantation hepatitis C Egyptian patients
Abstract
Background
IL28B gene polymorphisms are associated with the response to antiviral therapy in hepatitis C patients in th...
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
IgM antibody to hepatitis C virus in acute and chronic hepatitis C
To assess possible role of testing for IgM-specific antibody in the diagnosis and monitoring of patients with hepatitis C, we tested sera from 14 patients with acute and 97 patient...
Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
Cirrhosis and Rapid Virological Response to Peginterferon Plus Ribavirin Determine Treatment Outcome in HCV-1 IL28B rs12979860 CC Patients
Background. The rs12979860 CC genotype of the interleukin 28B (IL28B) polymorphism is associated with high rates of sustained virological response (SVR) to peginterferon (PegIFN) a...
IL28B Genetic Variations in Patients with Recurrent Herpes Simplex Keratitis
IL28B Genetic Variations in Patients with Recurrent Herpes Simplex Keratitis
Background and objectives: Recurrent herpes simplex keratitis (HSK) is the most common cause of corneal blindness in the developed world. A relationship between host gene polymorph...
ASSOCIATION OF THE SERUM LEVELS OF C-REACTIVE PROTEIN WITH ITS GENE POLYMORPHISMS AND ACUTE CORONARY SYNDROME
ASSOCIATION OF THE SERUM LEVELS OF C-REACTIVE PROTEIN WITH ITS GENE POLYMORPHISMS AND ACUTE CORONARY SYNDROME
Objectives
To investigate the association of the serum levels of CRP with its gene polymorphisms and the risk of ACS in Chinese Han population in Sunan region.
...

